About Luas Diagnostics
Luas Diagnostics is a company based in Guildford (United Kingdom) founded in 2020. Luas Diagnostics has raised $949.08 thousand across 4 funding rounds. The company has 3 employees. Luas Diagnostics offers products and services including Strepelle, HIV Self-Test, Other Infectious Diseases Tests, and Cancer Tests. Luas Diagnostics operates in a competitive market with competitors including Dexcom, Livongo, Bigfoot Biomedical, Prenetics and Senseonics, among others.
- Headquarter Guildford, United Kingdom
- Employees 3
- Stage Minicorn
- SectorsHealthcareTechnology
- Email••••••••
- Website luasdiagnostics.com
- Social LinkedIn X
- Legal Name Luas Diagnostics Ltd
- Date of Incorporation 08 Jun, 2020
- Jurisdiction LONDON, ENGLAND
- Total Equity Funding$949.08K (USD)
in 4 rounds
- Employee Count3
Products & Services of Luas Diagnostics
Luas Diagnostics offers a comprehensive portfolio of products and services, including Strepelle, HIV Self-Test, Other Infectious Diseases Tests, and Cancer Tests.
Home-to-laboratory test for Group B Streptococcus in pregnancy.
Single-use self-test for detecting HIV-1 and HIV-2 antibodies.
Range of tests for various infectious diseases at home or professionally.
Tests for early detection of cancer to improve clinical outcomes.
Funding Insights of Luas Diagnostics
Luas Diagnostics has successfully raised a total of $949.08K across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $949,082
- Total Rounds 4
- First Round $483,767
(Sep 2020)
All 4 funding rounds of Luas Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2023 | – | Seed | $3.01M | – | – |
| Apr 2021 | $48,544 | Seed | $3.34M | – | – |
| Jan 2021 | $416,771 | Seed | – | – | – |
| Sep 2020 | $483,767 | Seed | $••••• | – | – |
| Date | Valuation | Stage |
|---|---|---|
| Apr 2023 | $3.01M | •••••••• |
| Apr 2021 | $3.34M | •••••••• |
| Sep 2020 | $••••• | •••••••• |
Full valuation and stage history of Luas Diagnostics
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $3.01M (Apr 2023).
People of Luas Diagnostics
1 people are tracked at Luas Diagnostics (1 in leadership); the tracked headcount is 3.
| Name | Role | Group |
|---|---|---|
Brendan Farrell | Founder & Executive Chairman | Leadership |
Complete people profiles for Luas Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Luas Diagnostics
4 dated milestones of Luas Diagnostics across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Luas Diagnostics is founded.
- Funding First funding round of $484K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed,.
Competitors of Luas Diagnostics
Luas Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, Livongo, Bigfoot Biomedical, Prenetics and Senseonics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dexcom.com | 1999 | San Diego, United States | $52.5M | 9,600 | Wearable glucose monitoring patches are provided for real-time data tracking. | |
| livongo.com | 2014 | San Francisco, United States | $245.2M | 3,263 | Provider of smart devices for diabetes management for patients and doctors | |
| bigfootbiomedical.com | 2014 | Milpitas, United States | $214.51M | 133 | Developer of a closed-loop automated insulin delivery system | |
| prenetics.com | 2009 | Hong Kong, China | $67.65M | – | Health risks are identified through online genetic and diagnostic testing. | |
| senseonics.com | 1996 | Germantown, United States | $175.46M | 132 | Implantable continuous glucose monitoring systems are provided for diabetes management. | |
| onedrop.today | 2015 | New York, United States | $107.87M | 166 | Provider of workforce healthcare solutions | |
| opgen.com | 2002 | Rockville, United States | $77.51M | 100 | Developer of diagnostics and bioinformatics platforms for providers | |
| mysugr.com | 2012 | Vienna, Austria | $4.8M | – | Gamified apps for diabetes management and therapy are provided. | |
| janacare.com | 2011 | Newton, United States | $26.59M | – | Mobile-based diagnostics for diabetes prevention and management are provided. | |
| dayzerodiagnostics.com | 2016 | Boston, United States | $48.6M | 48 | Genome sequencing diagnostics for infectious diseases are developed. |
Detailed competitors of Luas Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Luas Diagnostics
Complete news archive for Luas Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Luas Diagnostics
10 companies that operate in the same segment as Luas Diagnostics (Diabetes), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Small molecule drugs for various therapeutic areas are developed. | 1995 | United States | USD 165 M | USD 49.8 M | 103 | |
Implantable continuous glucose monitoring systems are provided for diabetes management. | 1996 | Germantown, United States | USD 175.46 M | USD 22.47 M | 117 | |
Developer of a closed-loop automated insulin delivery system | 2014 | Milpitas, California, United States | USD 214.51 M | – | 133 | |
Provider of workforce healthcare solutions | 2015 | New York, New York, United States | USD 107.87 M | – | 166 | |
Diabetes care and reversal programs are provided to patients. | 2021 | Bengaluru, Karnataka, India | USD 26.7 M | USD 5.07 M | 677 | |
Provider of smart devices for diabetes management for patients and doctors | 2014 | San Francisco, California, United States | USD 245.2 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 194 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Luas Diagnostics
Luas Diagnostics was founded in 2020.
Luas Diagnostics is headquartered in Guildford, United Kingdom.
Luas Diagnostics is a funded company, having raised a total of $949.08K across 4 funding rounds to date. The company's 1st funding round was a Seed of $483.77K, raised on Sep 2020.
Luas Diagnostics has 3 employees.
Founded in 2020 and based in Guildford, United Kingdom, operations are focused on the health diagnostics sector. Sensors and a connected app are developed for diabetes management. A portable diagnostic device is utilized to detect enzyme-substrate complexes on electrodes in glucose monitors. Presence of drugs or metabolites in samples is identified at the electrode, with no drug sample required in the tested material.
Luas Diagnostics's top competitors include Dexcom, Senseonics and Bigfoot Biomedical.
Luas Diagnostics offers Strepelle, HIV Self-Test, Other Infectious Diseases Tests, and Cancer Tests.
The valuation of Luas Diagnostics is $3.01M as of Apr 2023.
Luas Diagnostics operates through Luas Diagnostics Ltd.